(HIBS) Direxion Daily SP500 High - Ratings and Ratios
3X, Inverse, Derivatives, Futures, Swaps
Description: HIBS Direxion Daily SP500 High
The Direxion Daily S&P500 High Beta Bear 3X Shares (HIBS) is an exchange-traded fund designed to provide investors with a leveraged inverse exposure to the S&P 500 High Beta Index, which comprises the 100 most volatile stocks in the S&P 500. By investing in financial instruments that offer 3X daily inverse exposure, the fund aims to magnify returns when the underlying index declines.
The underlying index tracks the performance of high beta securities, which are stocks that have historically exhibited significant price movements relative to the broader market. These securities are identified based on their daily price changes over the past 12 months, making them potentially more responsive to market downturns. As a non-diversified fund, HIBS may be more susceptible to significant losses if the market moves against its inverse exposure.
From a technical analysis perspective, the current price of HIBS is $13.32, indicating a decline from its 20-day SMA of $15.20 and 50-day SMA of $20.84. The 200-day SMA stands at $19.57, further suggesting a downtrend. The Average True Range (ATR) is 1.66, representing a 12.48% volatility. Given the current price is near the 52-week low of $12.01, it is likely that the fund will experience a bounce or consolidation in the short term.
Considering the fundamental data, the Assets Under Management (AUM) for HIBS stand at $23.10M USD, indicating a relatively small fund. This could result in liquidity issues or higher expense ratios. However, for traders seeking inverse exposure to high beta stocks, HIBS remains an option.
Forecasting the future performance of HIBS requires analyzing both technical and fundamental data. If the S&P 500 index experiences a significant decline, HIBS is likely to benefit from its 3X inverse exposure, potentially leading to a short-term price increase. Conversely, if the market rallies, HIBS will likely decline. Based on the current technical indicators and the funds characteristics, a potential trading strategy could involve closely monitoring the S&P 500s movements and adjusting positions accordingly. A break below the 52-week low could signal further declines, while a sustained move above the 20-day SMA might indicate a temporary reversal.
Additional Sources for HIBS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HIBS ETF Overview
Market Cap in USD | 25m |
Category | Trading--Inverse Equity |
TER | 1.09% |
IPO / Inception | 2019-11-07 |
HIBS ETF Ratings
Growth Rating | -85.1 |
Fundamental | - |
Dividend Rating | 7.17 |
Rel. Strength | -65.7 |
Analysts | - |
Fair Price Momentum | 4.11 USD |
Fair Price DCF | - |
HIBS Dividends
Dividend Yield 12m | 5.18% |
Yield on Cost 5y | 0.05% |
Annual Growth 5y | -19.45% |
Payout Consistency | 44.9% |
Payout Ratio | % |
HIBS Growth Ratios
Growth Correlation 3m | -97.1% |
Growth Correlation 12m | -53% |
Growth Correlation 5y | -97% |
CAGR 5y | -63.56% |
CAGR/Max DD 5y | -0.64 |
Sharpe Ratio 12m | -1.30 |
Alpha | -23.47 |
Beta | -4.706 |
Volatility | 56.59% |
Current Volume | 781.7k |
Average Volume 20d | 355.3k |
Stop Loss | 8.1 (-7.1%) |
As of July 09, 2025, the stock is trading at USD 8.72 with a total of 781,656 shares traded.
Over the past week, the price has changed by -7.04%, over one month by -22.29%, over three months by -76.27% and over the past year by -61.20%.
No, based on ValueRay´s Analyses, Direxion Daily SP500 High (NYSE ARCA:HIBS) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -85.09 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HIBS is around 4.11 USD . This means that HIBS is currently overvalued and has a potential downside of -52.87%.
Direxion Daily SP500 High has no consensus analysts rating.
According to our own proprietary Forecast Model, HIBS Direxion Daily SP500 High will be worth about 4.4 in July 2026. The stock is currently trading at 8.72. This means that the stock has a potential downside of -49.08%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 4.4 | -49.1% |